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ABSTRACT Members of the ancient family of Argonaute (Ago) proteins are present
in all domains of life. The common feature of Ago proteins is the ability to bind
small nucleic acid guides and use them for sequence-speciﬁc recognition—and
sometimes cleavage—of complementary targets. While eukaryotic Ago (eAgo) pro-
teins are key players in RNA interference and related pathways, the properties and
functions of these proteins in archaeal and bacterial species have just started to
emerge. We undertook comprehensive exploration of prokaryotic Ago (pAgo) pro-
teins in sequenced genomes and revealed their striking diversity in comparison with
eAgos. Many pAgos contain divergent variants of the conserved domains involved in
interactions with nucleic acids, while having extra domains that are absent in eAgos,
suggesting that they might have unusual speciﬁcities in the nucleic acid recognition
and cleavage. Many pAgos are associated with putative nucleases, helicases, and
DNA binding proteins in the same gene or operon, suggesting that they are in-
volved in target processing. The great variability of pAgos revealed by our analysis
opens new ways for exploration of their functions in host cells and for their use as
potential tools in genome editing.
IMPORTANCE The eukaryotic Ago proteins and the RNA interference pathways they
are involved in are widely used as a powerful tool in research and as potential ther-
apeutics. In contrast, the properties and functions of prokaryotic Ago (pAgo) pro-
teins have remained poorly understood. Understanding the diversity and functions
of pAgos holds a huge potential for discovery of new cellular pathways and novel
tools for genome manipulations. Only few pAgos have been characterized by struc-
tural or biochemical approaches, while previous genomic studies discovered about
300 proteins in archaeal and eubacterial genomes. Since that time the number of
bacterial strains with sequenced genomes has greatly expanded, and many previ-
ously sequenced genomes have been revised. We undertook comprehensive analysis
of pAgo proteins in sequenced genomes and almost tripled the number of known
genes of this family. Our research thus forms a foundation for further experimental
characterization of pAgo functions that will be important for understanding of the
basic biology of these proteins and their adoption as a potential tool for genome
engineering in the future.
KEYWORDS Ago, RNA interference, genome editing, horizontal gene transfer,
prokaryotic Argonaute proteins
Argonaute (Ago) proteins play the key role in the RNA interference (RNAi) pathwaysin eukaryotes. All known eukaryotic Agos (eAgos) bind small RNA molecules and
use them as guides for sequence-speciﬁc recognition of long RNA targets. Upon
recognition of the target, it can be cleaved by the intrinsic endonuclease activity of the
Ago protein (1–4). Alternatively, Ago proteins, especially the members of the family that
lack nuclease activity, can recruit partner proteins to the target RNA, leading to its
degradation and/or repression of its translation (5–7). Recognition of nascent RNA by
Received 3 September 2018 Accepted 20
November 2018 Published 18 December
2018
Citation Ryazansky S, Kulbachinskiy A, Aravin
AA. 2018. The expanded universe of
prokaryotic Argonaute proteins. mBio
9:e01935-18. https://doi.org/10.1128/mBio
.01935-18.
Editor Eleftherios T. Papoutsakis, University of
Delaware
Copyright © 2018 Ryazansky et al. This is an
open-access article distributed under the terms
of the Creative Commons Attribution 4.0
International license.
Address correspondence to Sergei Ryazansky,
s.ryazansky@gmail.com, or Alexei A. Aravin,
aaa@caltech.edu.
RESEARCH ARTICLE
Molecular Biology and Physiology
crossm
November/December 2018 Volume 9 Issue 6 e01935-18 ® mbio.asm.org 1
 o
n
 D
ecem
ber 18, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
some eAgos can also lead to modiﬁcation of the chromatin structure—DNA and
histone methylation—of the target locus (8–10).
The proteins that belong to the Ago family are also present in the genomes of many
bacterial and archaeal species (11, 12). Structural and biochemical studies of prokaryotic
Agos (pAgos) have provided key insights into the mechanisms of RNAi in eukaryotes
and revealed that Ago proteins directly bind short nucleic acid guides and can cleave
complementary targets (13–21). The same studies showed that pAgos can associate
with short DNA guides and preferentially recognize DNA targets, in contrast to all
known eAgos (17, 20, 22–28). Despite these differences, solved structures of several
pAgos and eAgos combined with their sequence alignments revealed a conserved
domain organization of these proteins (reviewed in references 12 and 59). All eAgos
and all pAgos except one that were experimentally characterized to date possess four
domains that are organized in a bilobal structure, with N- and PAZ (PIWI-Argonaute-
Zwille) domains forming one lobe and MID (Middle) and PIWI (P-element Induced
Wimpy Testis) domains forming another lobe (16, 18, 20, 29–34). The nucleic acids are
bound between the lobes; the MID and PAZ domains interact with the 5= and 3= ends
of the small nucleic acid guide, respectively, and the PIWI domain contains an RNase
H-like fold with a catalytic tetrad of conserved amino acid residues involved in the
target cleavage (18, 19, 23–25, 27, 28). The N-domain is the least conserved in Ago
proteins; it was proposed to facilitate RNA duplex unwinding during guide loading by
eAgos (35) and prevent extended duplex formation during target recognition by some
pAgos (23).
Until now only a few pAgos were characterized by structural or biochemical
approaches (see Fig. 1B). At the same time, earlier genomic studies revealed that up to
32% of the Archaea and 9% of the Eubacteria with sequenced genomes contain genes
encoding proteins from the Ago superfamily and showed that the diversity of pAgos is
far greater than that of eAgos (11, 12). Indeed, many pAgos contain substitutions of key
catalytic residues in the PIWI domain (and are probably inactive), and a large class of
pAgos lack the N- and PAZ domains (“short pAgos”), while many pAgos contain
additional domains absent in eAgos, either in the same protein or as a part of putative
operons. Furthermore, previous studies of the genomic context of pAgo genes revealed
that catalytically inactive pAgos are usually associated with several types of nucleases
from the SIR2, TIR, PLD, Mrr (which include proteins with novel RecB-like and RecB2
domains), or Cas4 family (11, 12). Mrr and Cas4 are related to a highly divergent family
of PD-(D/E)XK nucleases (36, 37). Furthermore, a subclass of pAgos was found in
association with Cas1 and Cas2 nucleases within the CRISPR loci (24). The diversity of
pAgos revealed by genomic studies together with few examples of biochemically
characterized proteins suggested new cellular functions for these proteins (38–41).
Beyond understanding functions of pAgos in their host cells, analysis of pAgos may
yield new proteins that can be potentially harnessed for biotechnology, in particular as
an alternative to the CRISPR/Cas genome editing tools (42).
Previous genomic studies identiﬁed a nonredundant set of 261 pAgos (11, 12).
However, since their discovery the number of bacterial strains with sequenced ge-
nomes has more than tripled, and many previously sequenced genomes have been
revised, resulting in the removal of some pAgo genes from the databases. Therefore, we
have undertaken comprehensive exploration of the diversity of pAgos using the latest
version of the RefSeq protein database for bioinformatic search. The results of the
search almost tripled the number of identiﬁed pAgo genes. Our analysis supports the
previously reported separation of pAgos into short pAgos and long pAgos (which by
themselves can be separated into two distinct clades) and reveals several subclasses
with signiﬁcant differences in the domain organization. These include variations in the
MID and PAZ domains involved in guide binding and substitutions of catalytic residues
in the PIWI domain. A large fraction of pAgos, including those that lack intrinsic
endonuclease activity, are associated with putative nucleases and other DNA binding
proteins. Overall, the great diversity of pAgos revealed by our analysis opens a way for
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exploration of their biochemical properties and cellular functions, as well as their use as
potential tools in genome engineering.
RESULTS
The expanded set of prokaryotic Argonaute proteins. To reveal the diversity of
pAgos and to get new insights into their evolution, we performed comprehensive
analysis of proteins that belong to the Ago family in sequenced genomes of prokaryotic
species. For this, we searched 116 million proteins fetched from the RefSeq NCBI
protein database using known pAgos as queries by PSI-BLAST. We found 1,010 pAgos
encoded in 1,385 completely and partially sequenced genomes of 1,248 eubacterial
and archaeal strains (Fig. 1; see also Table S1 in the supplemental material). In total,
pAgos were found in 17% of eubacterial and 25% of archaeal genera (Fig. 1A). The
majority (1,186, or 95%) of archaeal and eubacterial strains carry only one pAgo gene
(876 pAgos, or 86.7% of all proteins). However, the genomes of 57 strains carry two
pAgo genes, four strains carry three pAgo genes, and one strain encodes four pAgos.
pAgos are in general randomly distributed in different prokaryotic clades as the number
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FIG 1 Phylogenetic analysis of pAgo proteins. (A) The numbers of identiﬁed short and long pAgo proteins in the classes of Eubacteria and Archaea. Pink
asterisks near the clade names indicate the archaeal classes. The numbers on the right of each bar depict the number of genera encoding pAgos versus the
total number of genera with the complete or partially sequenced genomes in the corresponding class. (B) The circular phylogenetic tree of the nonredundant
set of pAgos constructed based on the multiple alignment of the MID-PIWI domains. The pAgo proteins were annotated as follows, from the inner to the outer
circles: the type of protein, in which long-A pAgos are colored in green (truncated variants without the PAZ domain, light green), long-B pAgos are light green
(truncated variants without PAZ, green), and short pAgos are orange; the type of the PIWI domain, depending on the presence of the catalytic tetrad DEDX;
the type of the 5=-end guide binding motif in the MID domain (the ﬁrst two conserved residues are indicated); the presence and the type of the PAZ/APAZ
domains in pAgos; and the superkingdom to which the corresponding pAgo belongs. Biochemically characterized pAgos (or the most similar redundant
homologs for RsAgo and TtAgo) with resolved structures are highlighted in red. The scale bar represents the evolutionary rate calculated under the JTTCAT
evolutionary model.
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of genera in each class that encode pAgos in their genomes correlates with the total
number of genera in the class (Fig. 1A; Fig. S1). The nonredundant set of pAgos with
the level of similarity of less than 90% comprises 721 proteins, which is almost triple the
number of previously identiﬁed pAgo proteins (11, 12).
As described below, the vast majority of pAgos have the MID and PIWI domains, but
many proteins lack the N- and PAZ domains conserved in eAgos. Therefore, we used
multiple alignments of the MID-PIWI domains to construct a phylogenetic tree of pAgos
(Fig. 1B; Fig. S2). The tree revealed three large clades of pAgos, while two proteins from
thermophilic archaea Thermoproteus uzoniensis and Vulcanisaeta moutnovskia could not
be unambiguously classiﬁed as belonging to any of these clades due to their high
divergence. Following Makarova and coauthors (11), we call one of these clades “short
pAgos” (Fig. 1B), as all proteins in this clade lack the N- and PAZ domains present in
eAgos. The majority of pAgos that belong to the other two clades include the PAZ
domain, and we therefore designate them as long-A and long-B. The diversity of pAgos
vastly exceeds the diversity of eAgos that were previously shown to form a single
branch on the phylogenetic tree of long pAgos (as illustrated in Fig. 1B) (11, 12).
The three clades of pAgos can be found in both archaeal and eubacterial species.
Furthermore, the majority of prokaryotic classes that include large numbers of genera
encode both short and long pAgos. However, some classes have a clear bias toward
short or long pAgo types; thus, genomes of Alphaproteobacteria predominantly encode
short pAgos, while Cyanobacteria predominantly encode long pAgos (Fig. 1A). pAgos
that belong to different clades can be found in the same genome (for the strains that
encode several proteins). For example, Enhydrobacter aerosaccus ATCC 27094 encodes
three short and one long-A pAgo, Parvularcula bermudensis HTCC2503 and Halomi-
cronema hongdechloris C2206 encode two short and one long-B pAgos, and Methylo-
microbium agile ATCC 35068 contains one short and one long-B pAgo. Generally, the
phylogenetic tree of pAgos has little similarity with the phylogenetic tree of host
species built using classic molecular markers such as rRNA genes, thus conﬁrming
previously published observations (11, 12) and suggesting that pAgos have mostly
spread through horizontal gene transfer (HGT). Notably, a few pAgos that have been
biochemically studied almost all belong to the long-A clade, while only two pAgos from
the long-B clade and no proteins from the short pAgo clade have been characterized
to date (indicated in Fig. 1B).
Domain architecture of pAgos. To gain further insight into the structural diversity
of pAgo, we analyzed their domain architecture. The exploration of multiple alignments
of PIWI, MID, and PAZ domains was used to identify the main structural and functional
features of pAgos. We did not include the N-domain in our analysis because it has the
lowest level of conservation, which impedes its identiﬁcation in diverse pAgos. Using
InterProScan and CDD-batch programs and the Pfam and Superfamily databases, we
also searched for other domains in pAgo proteins. This analysis allowed us to propose
a comprehensive classiﬁcation of the pAgo domain organization (Fig. 2).
As justiﬁed by their name, we found that all members of the short pAgo clade lack
the PAZ domain implicated in binding of the 3= end of a guide molecule. The majority
of short pAgos (470, or 81%) have only two domains, MID and PIWI. Six short pAgos
(1%) are further truncated and lack the MID domain, suggesting that they may be
unable to interact with a guide. In addition to the MID and PIWI domains, 106 short
pAgos (18%) that all belong to a single monophyletic branch encompass the APAZ
(“analog of PAZ”) domain (Fig. 1B and 2A). The APAZ domain has no sequence similarity
to PAZ and was previously described as a domain always associated with short pAgos
either as a part of the same protein or present in the same operon with short pAgos
(11). Almost all (102 out of 106) APAZ-containing short pAgos also carry domains
related to the SIR2 family (SIR2_1 subfamily) (Fig. 1B and 2A), which are considered to
be bona ﬁde nucleases (11, 12).
In contrast to short pAgos, the majority (378, or 90%) of pAgos that belong to the
long pAgo clades have the domain architecture similar to eAgos, including PAZ, MID,
Ryazansky et al. ®
November/December 2018 Volume 9 Issue 6 e01935-18 mbio.asm.org 4
 o
n
 D
ecem
ber 18, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
and PIWI domains (the N-domain was not included in the analysis). However, 31 pAgos
that undoubtedly belong to long pAgos based on alignments of their MID-PIWI
domains lack the PAZ domain, including previously characterized AfAgo from Archaeo-
globus fulgidus (13–15). These truncated long pAgos are scattered at different positions
on the phylogenetic tree, suggesting multiple independent cases of the loss of this
domain during evolution of long pAgos. One of these truncated proteins also lacks the
MID domain. On the other hand, 15 long pAgos that have the PAZ domain also carry
additional putative nucleic acid binding domains at their N termini: 7 pAgos contain
DNA-binding domains (Schlafen, PF04326, or lambda-repressor-like, SSF47413) and
8 pAgos contain a nucleic acid binding domain with the OB-fold (SSF50249) (Fig. 1B
and 2B).
Analysis of the diversity of MID, PIWI, and PAZ domains revealed signiﬁcant varia-
tions in their structures characteristic for different groups of pAgos (Fig. 1B and 2), as
described below. In particular, subsets of proteins from both clades of long pAgos
contain MID* domains with substitutions of key residues involved in interactions with
the guide 5= end; many long-A pAgos and all long-B and short pAgos contain PIWI*
variants with substitutions of essential catalytic residues; and most long-B pAgos
contain incomplete variants of the PAZ* domain involved in the 3=-guide interactions
(Fig. 2).
Binding of nucleic acid guides in the MID domain. The vast majority (1,001, or
99% of all proteins) of pAgos contain the MID domain that has been implicated in
binding of the 5= end of guide molecules. The resolved 3D structures of pAgos,
including AfAgo (pAgo of A. fulgidus) (13–15, 22), RsAgo (Rhodobacter sphaeroides) (25,
28), TtAgo (Thermus thermophilus) (17, 19, 23), and MjAgo (Methanocaldococcus jann-
aschii) (27), have shown that the MID domain anchors the phosphorylated 5=-guide
nucleotide by a set of conserved amino acid residues (Fig. 3). These interactions are
complemented by the PIWI domain that provides additional residues for 5=-guide and
divalent cation binding (13, 15, 19, 23, 25, 27, 28).
247
218
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FIG 2 The diversity of domain architecture of pAgo proteins. Various types of domain organization of short (A) and long (B) pAgo proteins are schematically
shown. The numbers on the right of each type are the frequency of its occurrence in the redundant set of proteins. Based on the presence of the DEDX tetrad
in the PIWI domain and the putative 5=-P guide binding motif in the MID domain, all long pAgos can be separated into four types shown here. Green PIWI
domains carry the active DEDX catalytic tetrad while turquoise PIWI* domains do not contain the canonical tetrad. Yellow MID domains contain different types
of the 5=-end guide binding motif as indicated, while light-yellow MID* domains carry substitutions of the crucial amino acid residues in this motif. Orange PAZ
domains have the full-sized pocket responsible for 3=-end guide binding, while light-brown PAZ* variants do not have the second subdomain. The OB-fold is
the nucleic acid-binding domain SSF50249; the DNA-binding domains are Schlafen domain with AlbA_2 (PF04326) or lambda-repressor-like domain (SSF47413).
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Four conserved residues of the MID domain (Y/R, K, Q, and K in crystallized pAgos,
e.g., Y463, K467, Q478, and K506 in RsAgo in Fig. 3C) and a bound divalent cation (Mg2
or Mn2) form a network of hydrogen bonds anchoring the 5=-phosphate, and also the
third phosphate of the guide molecule, into this basic pocket (13, 15, 18, 25, 27).
Multiple sequence alignment of the MID domains shows that these residues are highly
conserved in most pAgos (Fig. 3A and B). Accordingly, substitutions of these residues
were shown to disrupt pAgo-guide interactions (13, 14, 18, 25, 27). Two additional
semiconserved residues (e.g., T and N in RsAgo) (Fig. 3) contribute to binding of the
phosphate group and the base of the nucleotide in the second position of the guide,
respectively (Fig. 3C). Together, these residues constitute a conserved six-amino-acid
motif that is found in most pAgos (YKQTNK consensus for long pAgos, with the most
conserved residues shown in bold; indicated with red asterisks in Fig. 3A and B).
Interestingly, we found amino acid variations at the ﬁrst two positions of this motif,
which might be important for the function of different groups of pAgos. The ﬁrst two
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FIG 3 The structure of the 5=-end guide binding motifs in the MID domain. (A) A fragment of the multiple alignment of MID domains of several typical pAgo
proteins with different types of the 5=-end guide binding motifs. Red asterisks are the positions of amino acid residues involved in the binding of the 5=-P-guide
end. Black asterisks are the positions of amino acid residues involved in the binding of the 5=-OH end of a guide in the MID-OH pAgos. MID domains with the
YK-type 5=-P-end binding motif belong to the long pAgos; MID domains of the HK type belong to the short pAgos; MID domains of the RK type are characteristic
of short pAgos but can also be found in some long pAgos. The multiple alignments were manually edited to bring them in conformity to the structures shown
in panel C. The species names, NCBI taxon_id, the types of pAgos (long, short, and long truncated without the PAZ domain), and corresponding accession
numbers are shown at the left of the alignment. (B) The sequence logo of amino acid residues involved in the formation of the 5=-end binding pocket for long
pAgos, short pAgos, MpAgo-like pAgos with MID-OH, and long pAgos with MID* domain variants. The combined logo motif including positions characteristic
for canonical MID and MID-OH domains is shown. Red and black asterisks are amino acid positions speciﬁc for the 5=-P (MID) and 5=-OH (MID-OH) binding motifs,
respectively. (C) Structures of binary complexes of RsAgo, TtAgo, and MpAgo with guide molecules: 5=-P guide RNA for RsAgo, 5=-P guide DNA for TtAgo, or
5=-OH guide RNA for MpAgo. For RsAgo and TtAgo, only residues from the conserved YKQTNK motif are indicated; for MpAgo, MID-OH-speciﬁc residues
involved in interactions with the 5=-guide end are also shown (labeled with asterisks). PDB IDs are shown next to each structure.
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residues in the motif are usually YK in long pAgos; subsets of long-A pAgos contain KR,
RK, HK, or YY combinations, while long-B pAgos are almost exclusively YK variants. The
aromatic ring of the ﬁrst Y stacks on the ﬁrst base at the 5= end of a guide, thereby
contributing to the binding of the ﬁrst nucleotide within the MID pocket (13, 15, 25, 27,
28). In contrast to tyrosine, R is positively charged and not aromatic and so unable to
stack the ﬁrst base of the guide, as exempliﬁed in the structure of TtAgo (Fig. 3C) (18,
23); the structure of any pAgo with histidine at the ﬁrst position of the motif remains
unknown.
The conserved residues implicated in binding of the 5=-phosphorylated guide end
are present in the majority (80%) of long pAgos (Fig. 1B). However, 84 (20%) of long
pAgos have at least one amino acid substitution at the most conserved positions in the
5= binding motif in their MID* domain; namely, they do not contain Y/H/R at the ﬁrst
position of the YKQTNK motif and/or K/R/Y at the second position, and/or Q at the third
position, and/or K at the last position. A separate subgroup of these proteins (MID-OH),
which form a tight clade on the phylogenetic tree (Fig. 1B), includes pAgo from
Marinitoga piezophila (MpAgo) that was recently shown to bind guide molecules with
5=-OH instead of 5=-P ends (24). The multiple sequence alignment showed that this
group includes 9 pAgos (compared to 3 proteins identiﬁed in the previous study [24])
and that positions of amino acid residues involved in 5=-guide interactions in these
proteins overlap the positions of the 5=-P-end binding motif in other pAgos (Fig. 3A and
B). However, in comparison with most pAgos, these residues form a more hydrophobic
pocket for 5=-OH binding (Fig. 3C). In addition, the MID pocket of MpAgo does not bind
Mg2 ions (Fig. 3C) (24). The absence of guide contacts with the Mg2 ion is in part
compensated by interactions between the phosphates of second and third nucleotides
of guide RNA with lysine residues speciﬁc for this group of pAgos (K403 and K418 in
MpAgo; Fig. 3B and C). While the ﬁrst tyrosine of the YKQTNK motif that stacks with
the ﬁrst nucleotide base in the guide molecule in other pAgos is replaced with a
hydrophobic residue in the MID-OH domain, its role is taken by a preceding
aromatic residue (Y or F) that stacks from the other side of the same base (Y379 in
MpAgo; Fig. 3B and C).
Another 75 pAgos with noncanonical MID* variants, none of which is characterized
to date, belong to several distinct branches on the phylogenetic tree of pAgos, and
some of them are located close to the MID-OH pAgos (Fig. 1B). The alignment of these
sequences showed that in general they share the same YKQTNK motif, although the
conservation of individual positions is much lower than for canonical pAgos (see logo
in Fig. 3B; alignment in Data Set S1). It remains to be established whether these proteins
include any additional subgroups with noncanonical MID* domains of different spec-
iﬁcities, as already revealed for MpAgo, or whether they just represent divergent
variants of the same canonical motif.
In contrast to long pAgos, all short pAgos have the canonical 5=-P-end binding motif
(Fig. 3B). Interestingly, almost all of them contain HK and RK residues at the ﬁrst two
positions of this motif, instead of YK in long pAgos, further supporting their separation
into a distinct clade from long pAgos (Fig. 1, 2B, and 3A and B). Though none of short
pAgos was biochemically characterized to date, the conservation of key residues in the
MID domain strongly suggests that these proteins bind 5=-phosphorylated guide
nucleic acids similarly to most long pAgos and eAgos.
Endonuclease activity of the PIWI domain. Structural and biochemical studies of
several pAgos and eAgos demonstrated that the conserved tetrad of amino acid
residues in the PIWI domain (DEDX, where X is D, H, or K) is responsible for endonu-
cleolytic cleavage of the target upon its recognition by the Ago-guide complex (18–20,
24, 40). Similarly to previous reports (11, 12), we found that all pAgos that belong to the
short clade lack a canonical DEDX catalytic tetrad in the PIWI domain (PIWI* variants)
(Fig. 2A). Similarly to short pAgos, all proteins in the long-B clade also lack the catalytic
tetrad. In contrast, the majority of long-A pAgos (79%) have the canonical DEDX
catalytic tetrad in the PIWI domain, suggesting that they possess endonucleolytic
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activity. However, this branch also harbors pAgos with substitutions in the catalytic
tetrad, suggesting several independent events of the loss of endonuclease activity in
this branch.
Binding of the guide 3= end in the PAZ domain. It was previously shown that the
amino acid sequences of the PAZ domains of the pAgo proteins are divergent, but their
structural folds are similar. The full-length PAZ domain has two subdomains, each
consisting of two nucleic acid binding regions, which are oriented to form a hydro-
phobic pocket that anchors the 3= end of the guide strand in the binary pAgo-guide
complex (16, 18, 20, 28); a typical structure of PAZ is illustrated for TtAgo in Fig. 4A. The
ﬁrst subdomain consists of an oligosaccharide binding fold (OB-fold)-like structure with
one or two helices on one side and includes nucleic acid binding regions R1 and R4. The
second subdomain consists of an -helix and a -hairpin or loop structure, sometimes
followed by another -helix, and includes nucleic acid binding regions R2 and R3
(Fig. 4A) (16, 18, 20). In TtAgo, all four regions contribute to anchoring of the guide 3=
end in the PAZ pocket (Fig. 4A) (18). However, some pAgos, such as RsAgo and MpAgo,
contain incomplete variants of the PAZ domain that lack the second subdomain,
including regions R2 and R3, and therefore do not possess the PAZ pocket (24, 25, 28).
Nevertheless, structural analysis of the binary guide-MpAgo complex revealed that the
guide 3= end can still be bound in the incomplete PAZ domain, although with a
different orientation relative to TtAgo (24). These differences may possibly affect the
kinetics of guide binding, the stability of binary guide pAgo complexes, or their ability
to recognize complementary nucleic acid targets (see Discussion).
We determined how often the PAZ domain without the second subdomain (referred
to here as PAZ*) is present among long pAgos. As noted above, the structural elements
of PAZ involved in nucleic acid binding are organized by the four poorly conserved
regions, R1 to R4 (Fig. S3, as described in reference 28), with the DNA-binding -helix
in the second subdomain formed by stretches of 7 to 15 amino acids from region R3
(illustrated for TtAgo and Pyrococcus furiosus PfAgo in Fig. 4). Thus, we analyzed the
presence of this region as a signature of the second subdomain of PAZ in pAgos. Using
multiple sequence alignments of the identiﬁed PAZ domains, we found that R3 is found
FIG 4 PAZ domains in pAgo proteins. (A) The structure of the 3=-guide binding pocket in TtAgo (PDB
ID: 3DLH). Structural regions R1 to R4 forming the pocket are shown in surface representation. (B) A
general scheme of the PAZ and PAZ* domain structures in long pAgos. All PAZ domains can have R1, R2,
R3, and R4 regions. PAZ* is deﬁned as variants of PAZ lacking full-length region R3. No regions R1, R2,
and/or R4 could be detected in multiple alignments of some PAZ or PAZ* variants (shown by broken
boxes), but their actual presence needed to be tested due to their low conservation. The numbers show
how many long pAgos have corresponding domain structures. The pAgos with resolved structures
having PAZ and PAZ* domains are indicated. (C) The three-dimensional structures of PAZ (TtAgo and
PfAgo) and PAZ* (MpAgo and RsAgo) variants in crystallized pAgos and their binary complexes with DNA
(for TtAgo) or RNA (for MpAgo) guide molecules. Tyrosine and lysine/arginine residues from R3 in TtAgo
and PfAgo, probably involved in guide binding, are indicated. PDB IDs are shown next to each structure.
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in more than half of the PAZ domains in long pAgos, including most long-A pAgos
(Fig. 1B and 4A; alignment in Data Set S2), indicating their canonical two-lobe structure.
The rest of PAZ* domains are smaller and do not have R3, suggesting that they have
the one-subdomain organization without the nucleic acid binding pocket, as previously
observed for RsAgo and MpAgo. Interestingly, the PAZ* domain is found in almost all
long-B pAgos (Fig. 1B), suggesting that it was present in the common ancestor of this
group.
Phylogenetic analysis of APAZ domain-containing proteins. Previous analyses
identiﬁed the so-called APAZ domain that is present in some short pAgos as well as in
genes contained in putative operons containing short pAgos (11). The APAZ domain
was proposed to be the functional analog (but not homolog) of the PAZ domain (11)
or the N-domain (43) that is absent in short pAgos. To gain insight into the diversity and
phylogeny of APAZ-containing proteins, we iteratively searched the RefSeq protein
database by DELTA-BLAST using the sequences of known APAZ domains as queries. In
total, we found 5,385 protein hits. However, the vast majority (4,753, or 88%) of the
found proteins belonged to the HisG (PRK01686) and EIIB families (TIGR01996). We
therefore performed the reverse DELTA-BLAST search using them as queries to test if
these protein families were indeed related to the other APAZ proteins; however, we did
not ﬁnd any APAZ-containing proteins within obtained hits. Moreover, the hisG pro-
teins were found only among BLAST hits of the SIR2-APAZ protein from Sphingomonas
wittichii RW1, while EIIB proteins were found only among BLAST hits of the TIR-APAZ
protein from Chlorobium phaeobacteroides BS1. Thus, we concluded that HisG and EIIB
families were revealed artiﬁcially and are not related to the APAZ proteins, and we
excluded them all from the further phylogenetic analysis. The remaining set of APAZ
domains included 632 proteins.
The multiple alignments of APAZ domains were used to build their phylogenetic
tree, which revealed that the APAZ proteins can be separated into four large groups
designated Ia, Ib, IIa, and IIb and a ﬁfth group III of 18 proteins from several archaeal
species that have remote similarity to groups I and II (Fig. 5; alignment in Data Set S3).
All ﬁve groups are present in putative operons with pAgos. We further analyzed the
domain architectures of APAZ-containing proteins using InterProScan and the Pfam
and Superfamily databases. The ﬁrst group of APAZ proteins designated Ia includes 117
proteins that in addition to APAZ contain the SIR2 domain (the “SIR2-APAZ” type). The
majority of proteins in this group are short pAgos that also contain the MID-PIWI
domains; however, 31 proteins from this group lack the MID-PIWI domains. Since these
variants are scattered along different branches in this group, they might have inde-
pendently lost their MID-PIWI parts. In contrast, while a signiﬁcant part of APAZ
proteins from the four other groups are associated with pAgos, only one of them is
pAgo itself. Most proteins that belong to group Ib (150) are related to group Ia and also
contain SIR2 besides APAZ, but do not have MID and PIWI. There are also several
proteins in both groups Ia and Ib that lack SIR2 or any other domains (the “APAZ” type;
4 and 6 proteins for Ia and Ib, correspondingly). Most proteins of group IIa (122) are
characterized by the presence of the TIR domain on their N termini (“the TIR-APAZ”
type); one of them is short pAgo (also Fig. 2); 16 proteins in this group lack TIR domains.
Group IIb, which encompasses 225 proteins, is diverse: 112 proteins contain unchar-
acterized domain DUF4365 (“DUF4365-APAZ”), and 13 have the SIR2 domain, while 100
do not have any extra domains (“APAZ”). Our analysis of the DUF4365 domain has
shown that it corresponds to the recently identiﬁed RecB-like domain of the Mrr
subfamily of PD-(D/E)XK nucleases (see below) (11). Finally, the proteins from group III,
similarly to a major part of proteins from group IIb, do not have any other domains
except APAZ (the “APAZ” type).
APAZ-containing proteins are found almost exclusively in eubacterial species. The
analysis revealed tight reciprocal association between APAZ-containing proteins and
short pAgos. Indeed, although only one branch of short pAgos contains the APAZ
domain, the majority of other short pAgos that do not have APAZ themselves contain
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APAZ-containing genes in their operons (Fig. 1B and 2). Reciprocally, 397, or 63%, of all
genes with the APAZ domain are positioned close (within 10 genes on the same
genomic strand) to short pAgos, likely in the same operons (Fig. 5) (see below). Thus,
APAZ proteins are likely an integral component of functional pathways mediated by
short pAgos.
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FIG 5 Phylogenetic analysis of APAZ domains. The circular phylogenetic tree of the ﬁve groups of APAZ domains. The phylogenetic tree was annotated as
follows, from the inner to the outer circles: in the “protein type” circle the APAZ-containing proteins are colored according to their phylogenetic groups and
domain compositions, where each type of protein structure is exempliﬁed by the callouts with corresponding domain schemes; isolated APAZ domains in all
groups are shown in light blue; the “operon” circle indicates whether the APAZ-containing protein is found in a pAgo coding operon; the “pAgo fusion” circle
shows APAZ domains which are fused with short pAgo proteins; and the “kingdom” circle indicates the superkingdom to which the corresponding
APAZ-containing protein belongs.
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Functional classiﬁcation of proteins enriched in the genomic context of pAgos.
Analysis of the functions of proteins encoded in the same operons with pAgos might
shed light on the molecular pathways involving pAgos. We therefore analyzed the
genomic context of pAgos encoded in the 1,385 genomes of 1,248 strains and explored
the proteins encoded in their proximity. We deﬁned a window centered on pAgo
encompassing 20 genes (i.e., 10 genes upstream and 10 genes downstream of pAgo)
in each genome. The 16,274 proteins encoded in these windows were clustered into
orthogroups based on the sequence similarities that resulted in 1,892 orthogroups that
had at least 2 proteins (see Materials and Methods). The orthogroups contained 12,668
proteins, and the largest one comprised 298 related proteins (Table S2). We further
deﬁned pAgo operons that included only genes that are continuously located on the
same genomic strand as pAgo, which resulted in a set of operons with a mean size of
6.4 genes. We separately considered operons of ﬁve different groups of pAgos (Fig. 6):
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FIG 6 Functional annotations of proteins encoded in pAgo operons. The heat map on the left shows the percentage of operons for each pAgo group
(columns) that have at least one protein from the particular orthogroup (rows). The orthogroups are ordered according to the number of proteins in each
group, from the largest to the smallest. Since many operons do not contain any proteins included in the orthogroups analyzed here, the total number of
operons with orthogroup-speciﬁc proteins may be less than 100%. The PD-(D/E)XK column shows the fraction of proteins from each orthogroup that are
predicted to be nucleases from the PD-(D/E)XK superfamily. The annotation of proteins was performed by BLAST analysis for identiﬁcation of APAZ, RecB-like,
and RecB2 domains and by InterProScan using the Pfam and Superfamily databases. Only the Pfam annotation of domains is shown (with the exception of
og_209, for which the Superfamily annotation is shown). The percentage in the brackets after the domain name shows the fraction of proteins in the
corresponding orthogroup having this type of domain. Since proteins may contain several domains, the sum of percentages in each row may be greater than
100%. Only Pfam or Superfamily domains found in at least 30% of orthogroup proteins are shown. The descriptions of domain functions are shown on the
right of the panel. Proteins from several orthogroups do not have any known domains and are marked by “?.” After the manual curation of domain functions,
several of the most common functional features were selected, which are shown as colored symbols and described below the table.
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(i) short pAgos that are not fused to the APAZ domain, (ii) short pAgos that contain the
SIR2-APAZ domains, (iii) all long-A pAgos except the MID-OH variants, (iv) long-B pAgos,
and (v) long-A pAgos with the MID-OH domain. Proteins from 47 orthogroups that were
present in at least 5% of operons in at least one of the ﬁve pAgo groups were further
analyzed in detail. In Fig. 6, the orthogroups are sorted in descending order of the
number of proteins in each orthogroup.
We deﬁned the domain structure of proteins in each orthogroup using InterProScan
with Pfam, Superfamily, and CDD databases containing known domain annotations. For
identiﬁcation of the APAZ, RecB-like, and RecB2 domains, previously described by
Makarova et al. (11) and absent from these databases, we performed PSI-BLAST search
using previously identiﬁed proteins as queries. In addition, we proposed that there may
be other pAgo-associated proteins belonging to the PD-(D/E)XK superfamily of nu-
cleases, besides previously identiﬁed Mrr (RecB-like and RecB2) and Cas4 proteins (11,
12). To check this, we have searched for the characteristic PD-(D/E)XK sequence motif
in the orthogroup proteins. The identiﬁed domains found in each orthogroup of
proteins and the putative functional types of pAgo-associated proteins are shown in
Fig. 6.
The proteins with APAZ domains are present in the orthogroups og_3, og_4, og_9,
and og_40. The proteins from these orthogroups also contain other types of domains,
including DUF4365 (og_3), SIR2_1 subtype of SIR2 (og_4), TIR (og_9), and SIR2_1 fused
with Schlafen domain (og_40). Most of the revealed APAZ-containing proteins are
located in group 1 operons of short pAgos that do not have their own APAZ domain.
In total, 91% of group 1 operons contain proteins with APAZ. In contrast, only 6% of
group 2 operons of short pAgo fused with APAZ and SIR2 encode APAZ-containing
proteins. Taken together, 93% of short pAgos are associated with the APAZ domain as
a part of the same protein or present in the same operon with short pAgos. In contrast,
long pAgos are only rarely coencoded with APAZ proteins (2%, 3%, and 0% of operons
from groups 3, 4, and 5, respectively).
We found several different types of nucleases and DNA-binding proteins abundant
in the pAgo operons (Fig. 6). In total, 17 out of 47 orthogroups (36%) encode proteins
with putative nuclease activity. These proteins are found in 68% of pAgo operons.
Ninety-two percent of operons of short pAgos that themselves do not have the APAZ
and SIR2 domains (group 1 of pAgos) encode different types of nucleases. In contrast,
only 32% of operons of short pAgos fused with the SIR2 and APAZ domains (group 2)
contain nucleases. For group 3 of long-A pAgos, 45% of pAgos carrying the catalytic
tetrad have nucleases in their operons, while this number is increased to 53% for
operons of long-A lacking the DEDX tetrad. This number is further increased to 67% for
group 4 of long-B pAgos, which are all catalytically inactive. The nucleases found in the
pAgo operons are quite diverse and include proteins with SIR2 (og_4, og_40, and
og_44), TIR (og_9), and RecB2 (og_15) domains; the DUF4365 domain that belongs to
RecB-like nucleases (og_3); Cas4 proteins (og_56 and og_60), and phospholipase D
proteins with putative nuclease activity (og_136). A set of pAgo operons also contain
proteins with putative nucleases of the HNH type with DUF252 and DUF1254 domains
(og_28).
Two pAgos from Marinitoga piezophila and Thermotoga profunda, which are repre-
sentatives of the small group of long-A pAgos containing the MID-OH domain (Fig. 1B,
2B, and 3A), were previously reported to be encoded in the CRISPR loci between the
Cas1 and Cas2 genes (24). We found that all pAgos containing the MID-OH domain
from 9 prokaryotic strains (group 5 of pAgos) are encoded within CRISPR loci with Cas1
(og_154) and Cas2 (og_209) genes nearby (Fig. 6). Other proteins speciﬁc for the
subtype III-B CRISPR locus are also observed in association with MpAgo-like pAgos: Cas6
(og_190), primase (og_209), and Cmr (Cas module RAMP) proteins (og_455).
In addition, proteins in several other orthogroups have motifs characteristic for the
PD-(D/E)XK nucleases [Fig. 6, the PD-(D/E)XK column]. These proteins include the UvrD
helicase and P-loop NTPase (AAA subfamily) domains (og_6), SAM-dependent meth-
yltransferase domain (og_13), restriction endonuclease of type III (og_21, og_34), DEAD
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box helicase and P-loop NTPase (AAA subfamily) (og_34 and og_37), YhgA-type
putative transposases (og_72), and proteins without known domains (og_257 and
og_603). Notably, proteins from three of these orthogroups have predicted helicase
activity (domains related to the UvrD helicase, og_6, and DEAD box helicase, og_34 and
og_37).
Proteins with DNA-binding domains are abundant in operons of short pAgos fused
to the APAZ and SIR2 domains (33%) and of long-B pAgos (33%). In addition, proteins
with DNA-binding domains are present in 19% and 13% of operons of long-A pAgos
and short pAgos without APAZ-SIR2 domains, respectively. The DNA-binding domains
in pAgo-associated proteins include the lambda repressor-like DNA-binding domain
(og_2), helix-turn-helix DNA-binding domains (og_18, og_49, og_73, and og_79), the
Schlafen domain with an AlbA_2 subdomain (og_37), and DNA-binding components of
the type I restriction-modiﬁcation system (HsdS) (og_11). Interestingly, the lambda
repressor-like DNA-binding domain (PF01381) from highly represented orthogroup
og_2 and the Schlafen DNA-binding domain AlbA_2 (PF04326) from og_37 were found
to be fused with several long-B pAgos (Fig. 2B).
Overall, analysis of proteins in pAgo operons strongly indicates the involvement of
nuclease, helicase, and DNA-binding activities in cellular pathways dependent on
pAgos (see Discussion). Beyond nucleases and DNA-binding proteins, 10% of all long
pAgo operons encode hydrolases and phosphatases (og_47, og_62, and og_55). Finally,
14% of long-B pAgo operons encode multidrug efﬂux transporters of the resistance-
nodulation-cell division (RND) superfamily (og_14 and og_31), but their possible roles
in the functional pathways involving pAgos remain unknown.
In the present analysis, we could not reveal any deﬁned operon compositions for
speciﬁc pAgo groups. While the median number of all genes associated with pAgo on
the same strand is 6.4, these numbers are much lower if we consider only proteins
included in the orthogoups analyzed here: 2.0 for all short pAgos, 3.0 for each long-A
and long-B pAgo, and 5.0 for the MID-OH long-A pAgos. The small sizes of operons on
the one hand and the large number of orthogroups on the other result in numerous
possible operon conﬁgurations, making the construction of the consensus operon
structure impossible. The only exception is the MID-OH long-A pAgos, for which the
structure can be presented as Cas1-Cas2-Cas6-pAgo-Cmr. The same operon scheme
was reported for MpAgo previously (24). The list of all observed conﬁgurations of
orthogroup proteins in pAgo operons is presented in Table S3.
The genomes encoding pAgos do not show decreased transposon copy num-
ber. Several eukaryotic Ago proteins were shown to prevent propagation of trans-
posons and viruses in the genomes (reviewed in references 44 and 45). Similarly, a few
studied pAgos were proposed to protect prokaryotic cells from foreign DNA, including
plasmids, transposons, and phages (38, 40, 41). In particular, pAgos may be involved in
the protection of the prokaryotic genome from the invasion of mobile genetic elements
or suppress the activity of genomic copies of such elements. If pAgos are able to reduce
the expansion of transposons in their host genomes, then the number of transposon
insertions should be lower in strains that encode pAgo. To test this hypothesis, we
counted the number of transposon insertions in the genomes of strains encoding or
not encoding pAgos from different groups (short pAgos, short pAgos fused to the
SIR2-APAZ domains, long-A with PIWI and PIWI* domains, long-B pAgos, and long-A
pAgos with the MID-OH domain). We found that the genomes of strains encoding
pAgos do not have lower copy numbers of transposons than strains without pAgo
genes (Fig. 7A). Moreover, we observed a moderate but signiﬁcant increase in the mean
number of transposon copies per genome in pAgo-contaning strains for both short and
long classes of pAgos. For the MID-OH pAgos, the number of transposon copies in
corresponding genomes was smaller than in pAgo-minus strains, but this difference
was statistically insigniﬁcant due to the small number of pAgos in this group. Since
different phylogenetic groups may contain different transposon numbers, we com-
pared the transposon content within several genera (Fig. 7B). For this, we selected 32
prokaryotic genera having at least 10 strains with sequenced genomes encoding and
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not encoding pAgos. For the strains of each genus, the transposon copy numbers were
subjected to log2 transformation and z-scaling. If a strain has a z-score of 2, then
there is only a 2.3% chance that its genome has the transposon content typical for this
genus, and so it can be considered the one that has a signiﬁcantly lower transposon
number than average. We have found that only one strain among 108 pAgo-encoding
strains from 32 genera (703 strains in total) has a z-score of2 (Fig. 7B). The genomes
of all other strains with pAgo have the transposon copy numbers that are typical of the
corresponding genera. Overall, our results indicate that pAgos present in the genomes
may not be able to stop transposon insertions; however, this does not exclude a
possibility that pAgos can repress transposon expression.
DISCUSSION
Eukaryotic systems of RNA interference have evolved from several diverse prokary-
otic components, including RNase III-like enzymes, RNA-dependent RNA polymerases,
helicases, and pAgos, which gave rise to various types of eAgos and RNAi pathways
(46). While being highly variable and involved in different interference pathways, all
eAgos share the samemodus operandi: they always bind small RNA guides to locate and
inactivate cRNA targets (or attract other components to modify corresponding coding
DNA loci). Perhaps not surprisingly, pAgos are much more diverse, with signiﬁcant
sequence and domain variations (11, 12). Moreover, a few published functional studies
of pAgos demonstrated that, while retaining the same basic principle of guided nucleic
acid recognition, they may signiﬁcantly differ in their modes of action in comparison
with eukaryotic counterparts (38–41, 47). We have now revealed even a larger diversity
of pAgos that allows us to suggest their updated classiﬁcation and propose possible
evolutionary pathways and cellular functions for this conserved family of nucleic
acid-targeting proteins.
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FIG 7 The number of transposon copies in genomes with and without pAgo genes. (A) The violin plot shows the log2-transformed distribution of copy numbers
of transposons in the genomes of prokaryotic strains encoding or not encoding pAgos. The black dots with whiskers indicate the means and standard
deviations. The numbers of analyzed genomes for each group of pAgos are shown below each violin. The P values shown above the plot were calculated with
the Wilcoxon two-sided rank test: ****, P value  1 104; ***, P value  1 103; **, P values  0.05. (B) The violin plot shows log2-transformed and z-scaled
distribution of copy numbers of transposons in the genomes of prokaryotic strains encoding or not encoding pAgos for selected genera. The colored dots
indicate the transposon content of strain genomes encoding pAgos; the correspondence of pAgo type and dot color is speciﬁed above the plot. The numbers
of analyzed genomes for each genus are shown above each violin (strains with pAgo/total number of strains).
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The diversity of pAgos. Our results revealed that pAgos are widespread in archaeal
and eubacterial species. The availability of new sequenced genomes allowed identiﬁ-
cation of an almost 3-fold-larger set of pAgos than previous analysis. Analysis of this
expanded set demonstrated that pAgos are highly diverse and can be separated into
three large clades, short, long-A and long-B, which diverged early in evolution (Fig. 1B;
see also Fig. S1 in the supplemental material). While this division is based solely on
sequence alignments of the MID-PIWI domains, these groups also reveal characteristic
variations in speciﬁc structural elements involved in nucleic acid binding and process-
ing. Thus, the members of the long-A clade mostly contain both catalytically active PIWI
domains and PAZ domains of normal size. In contrast, long-B pAgos contain inactive
PIWI* domains and also usually shortened PAZ* domains, although other combinations
were also observed for both clades (Fig. 1 and 2). Furthermore, proteins from the long-A
clade contain several variants of the 5=-P-guide binding motif while long-B pAgos
almost always contain the canonical YK motif. Short pAgos always contain substitutions
in the active site (PIWI*) and a subset of canonical MID motifs (HK/RK).
The exact relationship between the three clades is ambiguous, with two possible
alternative scenarios (12). In one scenario, short and long pAgos diversiﬁed ﬁrst,
followed by a further split of long pAgos into two clades. Alternatively, catalytically
inactive long-B pAgos and short pAgos may have originated from a common ancestor
containing substitutions in the active site. The phylogenetic analysis of the MID-PIWI
domains has shown that the evolutionary distance between combined short pAgo and
long-B pAgo clades on the one side and the long-A clade on the other is slightly larger
than between short and combined long-A and long-B clades (Fig. S1). This argue in
favor of the second scenario of the evolutionary origin of the three clades of pAgos.
Binding of nucleic acids by pAgos. Tight association with small nucleic acid guides
seems to be a deﬁning feature of pAgos and eAgos alike (reviewed in references 12 and
59). Analysis of the nucleic acid binding pockets of the MID domain revealed that the
majority of pAgos that belong to all three clades (short, long-A, and long-B) likely bind
small nucleic acid guides with monophosphorylated 5= ends. At the same time, we
discovered signiﬁcant variations in the conserved 5=-guide binding motifs in the long-A
pAgos, including substitutions of key residues involved in the 5=-phosphate interac-
tions (i.e., YK, YY, KR, YR, MID*, and MID-OH variants). While most these variants likely
interact with 5=-P-guides, some proteins might bind guides with an alternative 5=-end
structure, as already shown for the MID-OH pAgos, or not use nucleic acid guides at all.
Interestingly, almost all members of the short pAgo clade have MID variants that are
close to the consensus (HK/RK), suggesting that the canonical MID pocket structure is
essential for their function in the absence of the PAZ domain. Future biochemical
comparisons of the long and short pAgos with various noncanonical MID motifs should
ﬁnd out if the observed differences in the 5=-end pockets may inﬂuence the speciﬁcity,
afﬁnity, and kinetics of their interactions with guide and target molecules.
While all known eAgos use small RNA guides to recognize RNA targets, the majority
of proteins in a relatively small sample of pAgos characterized so far prefer to bind
small DNA as a guide, except for RsAgo (38) and MpAgo (24), which associate with small
RNAs. Furthermore, all studied pAgos preferably interact with DNA targets. Few amino
acid residues involved in the binding of ribose and deoxyribose backbone of the guide
and target molecules were identiﬁed in the structures of experimentally characterized
pAgos (17, 23–25, 28); however, these residues are not well conserved. Therefore,
sequence analysis is not able to predict preference for DNA versus RNA binding, and
this information has to be obtained experimentally.
The PAZ domain of most studied eAgo and pAgo proteins is composed of two
subdomains that together form the 3=-end guide binding pocket (16, 18, 20, 28).
However, our results revealed different organizations of the PAZ domain among long
pAgos, indicating that a single conserved structure of PAZ may not be required for
guide binding. The structure is not conserved even among the few experimentally
characterized pAgos. While AaAgo and TtAgo contain both subdomains (18, 20), the
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PAZ* domains of MpAgo and RsAgo lack the second subdomain and therefore do not
possess the PAZ pocket (24, 25, 28). While no three-dimensional structure of the binary
complex is available for RsAgo, the guide 3= end still interacts with PAZ in the binary
complex of MpAgo but is differently oriented (Fig. 4) (24). Formation of the extended
guide-target base-pairing during target recognition is accompanied by guide release
from PAZ (19, 23, 24, 26, 48). Thus, structural characteristics of PAZ may have an
important role in the recognition and binding of nucleic acid targets by pAgo proteins,
for example, by inﬂuencing the kinetics of target recognition and cleavage (19, 23, 24,
26, 48, 49). Interestingly, the incomplete PAZ* domain is characteristic for the long-B
clade of catalytically inactive pAgos, suggesting that the stepwise guide-target anneal-
ing controlled by full-length PAZ may be more important in the active long-A pAgos,
e.g., for prevention of premature nonspeciﬁc target cleavage.
All short pAgos and a small but signiﬁcant fraction of long pAgos lack the PAZ
domain entirely, raising the question of how nucleic acid guides can be bound by these
proteins. Structural and functional analysis of the truncated long-A AfAgo lacking the
PAZ domain demonstrated that it can nevertheless bind and stabilize short guide-
target duplexes (14, 15, 22). Furthermore, since the guide 3= end is released from the
PAZ domain upon target recognition, PAZ may be important for protection of the guide
from cellular nucleases until the target is found—and the protection may be less
important for short pAgos or truncated long pAgos that use DNA guides. However, it
remains to be established whether any accessory proteins may facilitate guide and
target binding by such pAgos. The ﬁnding of association between short pAgos and the
APAZ domain led to the suggestion that APAZ might play the role of PAZ in short
pAgos (11). Recently, it was proposed that APAZ may be instead homologous to the
N-domain of full-length Agos (43). However, both proposals await experimental vali-
dation.
Possible functional activities of pAgo-associated proteins. In contrast to their
ability to bind nucleic acids, the endonuclease activity toward the target is not a
universal feature of pAgos: the proteins that are predicted to have the catalytic tetrad
in the PIWI domain are found in only the long-A clade of pAgos (18% of all pAgos).
However, the lack of catalytic activity in PIWI* does not rule out the possibility that such
pAgos are involved in processing of target nucleic acids. Indeed, our analysis conﬁrmed
and expanded previous observations on the association of catalytically inactive pAgo
with proteins that might have nuclease activity (11, 12). Markedly, the number of
putative nuclease genes in operons containing catalytically inactive pAgo variants is
signiﬁcantly higher than for the active pAgos.
The proteins in one branch of short pAgos have the SIR2 domain with potential
nuclease function, while many more pAgos that belong to the short and long-B clades
of catalytically inactive pAgos harbor in their operons separate proteins with predicted
nuclease activities. The absence of the catalytic tetrad in the PIWI* domain in such
pAgos and their tight association with proteins containing SIR2, TIR2, DUF4365 (novel
RecB-like nuclease of the Mrr subfamily), RecB2, Cas4, PLD, and HNH nuclease domains
suggest that these domains might replace the intrinsic endonuclease activity of the
Ago protein. Although the APAZ domain is not related to any nuclease, its strong
association with short pAgos and the proteins with nuclease domains suggests that
APAZ might also be involved in the nuclease activity. Thus, the functions of target
recognition and its further processing seem to be separated, with the ﬁrst step
performed by pAgos and the second by nucleases encoded in the pAgo operons.
Notably, these operons often include predicted helicases and DNA-binding proteins,
suggesting their involvement in DNA processing. Future analysis of the functional
activities of these proteins will be required to uncover the molecular details of pAgo
action.
Possible functions of pAgos in prokaryotic cells. eAgos and their small RNA
partners play diverse functions, from the repression of selﬁsh genomic elements such
as transposons to the regulation of host gene expression. Furthermore, eAgos can
Ryazansky et al. ®
November/December 2018 Volume 9 Issue 6 e01935-18 mbio.asm.org 16
 o
n
 D
ecem
ber 18, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
direct changes of chromatin marks and even DNA elimination (44, 45). Compared to
eAgos, experimental data about pAgo functions are very scarce, as activities of only a
few proteins were characterized in vitro and even smaller numbers of proteins (TtAgo
and RsAgo) were studied in their host cells in vivo. Available data suggest that pAgos
might participate in protection of prokaryotic genomes against foreign elements such
as plasmids, transposons, and phages (38, 39). However, the only direct results obtained
so far were the ability of TtAgo and RsAgo (and also PfAgo and MjAgo in the
heterologous Escherichia coli system) to decrease the amount of plasmid DNA in the cell
(38–41). RsAgo was also demonstrated to decrease plasmid transcription and prefer-
entially associate with genomic DNA sequences corresponding to transposons and IS
elements (38). While the molecular mechanisms of this speciﬁc targeting remain to be
established, we infer that other types of pAgos discovered in our analysis may also be
involved in host defense against certain types of genetic elements.
Intriguingly, we observed a positive, not negative, correlation between the presence
of various types of pAgos and the number of transposon copies in sequenced genomes.
This observation suggests several possibilities. First, transposons may not be the main
targets of all pAgos, most of which may instead target phages and plasmids. Second,
the presence of pAgos in genomes with increased transposon numbers might be
beneﬁcial for these strains because pAgos suppress the transposon expression or their
further detrimental transpositions. Third, it can be speculated that pAgos might per-
form a plethora of other functions in prokaryotic cells, including genetic regulation and
DNA repair. Indeed, association of pAgos with multiple DNA-binding and DNA-
processing proteins suggests their active involvement in DNA metabolism in prokary-
otic cells.
As reported previously (11, 12) and in this work, the pattern of distribution of pAgos
among eubacterial and archaeal species does not correspond to the phylogeny of host
species, suggesting their spread by horizontal gene transfer. While we could not build
a conserved operon structure for any group of pAgo proteins, their strong association
with genes encoding proteins involved in DNA processing suggests their common
function and joint horizontal transfer. Statistical analysis of the genomic neighborhoods
of pAgos also revealed a signiﬁcant link to phage resistance systems (11). The functional
roles of such associations should be investigated experimentally. Other genes spread
by HGT include various adaptation and resistance systems such as CRISPR, restriction/
modiﬁcation, drug resistance, and toxin/antitoxin modules that have common features
of cell protection in the highly diverse and developing environments. While it is
attractive to suggest that most pAgos use associated nucleic acid guides for sequence-
speciﬁc recognition of foreign DNA targets in order to repress them, other scenarios of
their action are possible as well. For example, pAgos together with their protein
partners might constitute a suicidal system that is activated under stress conditions or
upon viral infections and triggers processing of host DNA unless its activity is sup-
pressed. Our study opens new possibilities for detailed analysis of various groups of
pAgos and associated factors, which can reveal their new cellular functions and
activities and possibly adopt pAgos as an efﬁcient tool for genomic manipulations.
MATERIALS AND METHODS
Prokaryotic protein and genome databases. The set of proteins was downloaded from the NCBI
FTP site in January 2018. Altogether, the database included more than 116 million RefSeq proteins from
4,364 taxons with completely sequenced and assembled genomes (“Complete Genome” and “Chromo-
some” statuses) and 15,505 taxons with unassembled genomic sequences (“Scaffold” and “Contig”
statuses) of Archaea and Eubacteria. The genomic sequences and genome annotations of prokaryotes
were fetched from the NCBI FTP site in January 2018.
Identiﬁcation of pAgo- and APAZ-containing proteins and analysis of their domain structure.
The identiﬁcation of homologs of already-known pAgo- and APAZ domain-containing proteins was
carried out using the PSI-BLAST and DELTA-BLAST program from the NCBI-BLAST package, v.2.6.0
(-num_descriptions 1000 -num_alignments 1000 -evalue 10E5 -num_iterations 5) (50). The search was
performed with ﬁve iterations, sufﬁcient for the full convergence of the results. For the search, sequences
of only the PIWI-MID domains of already-known pAgos (12) or APAZ domains (11) were used as queries.
The domain architecture of the found proteins was analyzed by the CDD-batch program (https://www
.ncbi.nlm.nih.gov/Structure/bwrpsb/bwrpsb.cgi) for the Pfam and CDD databases as well as InterProScan
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(v.5.28-67) for the Pfam and Superfamily databases. The proteins were aligned by the MAFFT program,
v.7.3 (-ep 0 –genafpair –maxiterate 1000) (51); multiple alignments were manually curated and used for
the extraction of domain borders and features.
Phylogenetic analysis. To construct a nonredundant, representative sequence set for the phyloge-
netic analysis, sequences of the PIWI-MID and APAZ domains were clustered using the UCLUST 4.2
program (52) with the sequence identity threshold of 90%. The longest sequence was selected to
represent each cluster. The multiple alignment of PIWI-MID domains was carried out by the MAFFT
program, v. 7.3 (-ep 0 –genafpair –maxiterate 1000) (51). Positions including greater than0.5 gaps were
removed from the alignment by trimAl, v.1.4 (53). Phylogenetic analysis was performed using the
FastTree program (54) with default parameters, with the WAG evolutionary model and the discrete
gamma model with 20 rate categories. The tree structure was validated with bootstrap analysis (n 100).
Analysis of the composition of pAgo operons. The protein-coding sequences of 16,264 genes
neighboring all pAgo genes (10 upstream and 10 downstream genes for each pAgo) were clustered
based on sequence homology. The pairwise similarity was calculated by using the proﬁle-proﬁle metric
with HHblits and HHsearch from the HH-suite (55, 56), as suggested in reference 57. In contrast to the
more common sequence-sequence comparison method with using all-against-all BLAST analysis, the
comparison of HMM proﬁles represents a more sensitive strategy for detecting distant evolutionary
relationships among diverged proteins. For this, a proﬁle for each sequence was constructed with HHblits
(-n 1 -E 1E3) and the uniclast30_2017_10 HMM database (http://wwwuser.gwdg.de/~compbiol/
uniclust/2017_10/). Then, all-against-all proﬁle–proﬁle search was conducted using HHsearch (-b 1 -b
1000 -z 1 -Z 1000 -E 1E5), which provided E values similar to what BLAST does. Clustering of genes into
orthogroups was done with the MCL algorithm implemented in the clusterMaker2 plug-in of Cytoscape
3.6.1 (inﬂation factor  2).
The annotation of obtained 1,892 protein orthogroups was performed with InterProScan (v.5.28-67)
for the Pfam and Superfamily databases. Also, we have performed the PSI-BLAST search of APAZ,
RecB-like, and RecB2 domains in the orthogroup proteins. The prediction of nucleases belonging to the
PD-(D/E)XK superfamily was carried out with an SVM-based approach using the standalone version of the
“PDEXK recognition” program kindly provided by Mindaugas Margelevicˇius (58). For each pAgo operon,
we then determined the orthogroups to which operon genes belonged to. If a pAgo was encoded in
several genomes, only the genome with the largest operon was selected for ﬁnal counting. Only
orthogroups that were present in at least 5% of operons for each pAgo type (minimum three operons
of any type of pAgo operon) were kept.
Counting the transposon copy number in genomes. The transposon insertions in genomes were
counted using genomic annotations of prokaryotic strains fetched from NCBI. Only genomes with
statuses “Complete Genome” and “Chromosome” were taken into account. For each genome, we
counted the number of occurrences of keyword “insertion sequence” or “transposase” in the genomic
annotation ﬁle. If there were several completed genomes for a given strain, then the median number of
log2-transformed transposon insertions was calculated. If a pAgo gene was found in different strains
of the same species (having the same taxon_id in the NCBI annotation), then the median number of
transposon insertions among all strains was taken. For the comparison of transposon contents of strains
encoding or not encoding pAgos within a genus, the additional z-scaling was performed.
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